NASDAQ:NTLA - Intellia Therapeutics Price Target & Analyst Ratings

-0.50 (-2.90 %)
(As of 08/22/2019 11:19 AM ET)
Today's Range
Now: $16.73
50-Day Range
MA: $17.18
52-Week Range
Now: $16.73
Volume4,108 shs
Average Volume510,352 shs
Market Capitalization$812.07 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Intellia Therapeutics (NASDAQ:NTLA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for Intellia Therapeutics in the last 12 months. Their average twelve-month price target is $26.3571, suggesting that the stock has a possible upside of 57.54%. The high price target for NTLA is $57.50 and the low price target for NTLA is $16.00. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.632.56
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.3571$26.3571$29.10$31.75
Price Target Upside: 57.54% upside68.09% upside96.36% upside148.24% upside

Intellia Therapeutics (NASDAQ:NTLA) Consensus Price Target History

Intellia Therapeutics (NASDAQ:NTLA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/8/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$23.00MediumView Rating Details
6/10/2019Roth CapitalInitiated CoverageNeutral$16.00HighView Rating Details
5/28/2019Chardan CapitalReiterated RatingBuy$57.50LowView Rating Details
5/3/2019WedbushUpgradeNeutral ➝ Outperform$20.00 ➝ $21.00HighView Rating Details
4/11/2019Evercore ISIInitiated CoverageOutperformHighView Rating Details
2/7/2019BTIG ResearchInitiated CoverageBuy$20.00HighView Rating Details
11/27/2018Leerink SwannInitiated CoverageOutperform$23.00HighView Rating Details
10/31/2018OppenheimerReiterated RatingHoldHighView Rating Details
10/29/2018Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$24.00HighView Rating Details
9/20/2018Raymond JamesInitiated CoverageMkt Perform ➝ Market PerformHighView Rating Details
3/8/2018JMP SecuritiesInitiated CoverageMkt Outperform ➝ OutperformHighView Rating Details
3/7/2018BarclaysBoost Price TargetOverweight ➝ Overweight$33.00 ➝ $46.00MediumView Rating Details
10/31/2017Jefferies Financial GroupSet Price TargetBuy ➝ Buy$36.00 ➝ $42.00N/AView Rating Details
(Data available from 8/22/2017 forward)
This page was last updated on 8/22/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel